Being diagnosed with colorectal cancer can be scary and confusing. Dr. Jeffrey Meyerhardt, an expert in colorectal cancer, describes the 4 questions that any newly diagnosed patient should ask.
The 2018 Cancer Survivorship Symposium: Advancing Care and Research will address key issues in promoting well-being in people who have finished active cancer treatment, covering topics such as exercise, follow-up care in young adult survivors, and better support for sexual problems.
One of the studies that will be presented at the Gastrointestinal Cancers Symposium this week has found that a liquid biopsy test can accurately find early-stage colorectal cancer.
In this podcast, Dr. Noelle LoConte discusses a recent statement from the American Society of Clinical Oncology that covers the link between drinking alcohol and developing cancer.
Cancer.Net’s Associate Editors discuss the most exciting research presented at the 2017 ASCO Annual Meeting.
ASCO Annual Meeting 2017: Symptom Reporting Extends Lives, Shorter Chemotherapy for Some Colon Cancer Patients, and Targeted Therapy in BRCA-Related Breast Cancer
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Research released today covers how using a web-based system to report symptoms helps patients live longer, a shorter schedule of chemotherapy can be an option for certain people with colon cancer, and a targeted therapy may slow the growth of BRCA-related breast cancer.
ASCO Annual Meeting 2017: News on Breast Cancer, Prostate Cancer, TRK Fusion Protein Inhibition, Using Blood Tests to Screen for Cancer, and Genomic Testing
Oncology professionals from around the globe are in Chicago for the ASCO Annual Meeting. Research highlights from today include pregnancy after breast cancer, abiraterone for prostate cancer, a new medication that targets a rare genetic abnormality, new blood test technology for cancer screening, and genomic testing.
At the 2017 Clinical Immuno-Oncology Symposium, new research will be presented on the link between gut bacteria and immunotherapy for melanoma and the impact of tumor location in predicting survival from colorectal cancer.
The 2017 Clinical Cancer Advances report of the American Society of Clinical Oncology has announced that the Advance of the Year is Immunotherapy 2.0. Why 2.0? Because the role of immunotherapy in cancer care is expanding, and oncologists are learning how to use it more effectively.